Larry Michael Mertz - May 22, 2023 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Signature
/s/ David Patience, attorney-in-fact
Stock symbol
AXDX
Transactions as of
May 22, 2023
Transactions value $
-$2,506
Form type
4
Date filed
5/24/2023, 08:03 PM
Previous filing
Mar 6, 2023
Next filing
Jun 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXDX Common Stock Options Exercise $0 +10K +1.94% $0.00 526K May 22, 2023 Direct F1
transaction AXDX Common Stock Sale -$1.95K -2.71K -0.52% $0.72 524K May 22, 2023 Direct F2
transaction AXDX Common Stock Options Exercise $0 +2.84K +0.54% $0.00 526K May 22, 2023 Direct F3
transaction AXDX Common Stock Sale -$554 -769 -0.15% $0.72 526K May 22, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXDX Employee Restricted Stock Units Options Exercise $0 -10K -50% $0.00 10K May 22, 2023 Common Stock 10K Direct F1
transaction AXDX Employee Restricted Stock Units Options Exercise $0 -2.84K -50.01% $0.00 2.84K May 22, 2023 Common Stock 2.84K Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 30,000 restricted stock units, which vests in equal amounts every year over three years, which started vesting on May 20, 2022.
F2 The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F3 The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 8,507 restricted stock units, which vests in equal amounts every year over three years, which started vesting on May 20, 2022.